Advertisement
Advertisement

ADIL

ADIL logo

Adial Pharmaceuticals, Inc

1.43
USD
Sponsored
+0.01
+0.70%
May 08, 15:50 UTC -4
Closed
exchange

After-Market

1.44

+0.01
+0.91%

Adial Pharmaceuticals, Inc Profile

About

Adial Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It focused on the development of a therapeutic agent for the treatment of alcohol use disorder. The company's lead product consists of AD04 which is in clinical stage. Adial Pharmaceuticals Inc. is based in CHARLOTTESVILLE.

Info & Links

CEO

Cary Claiborne

Headquarters

4870 SADLER ROAD, SUITE 300
Glen Allen, VA 23060, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.adial.com

Auditor

Marcum LLP

Share holders

85

Employees

6

Adial Pharmaceuticals, Inc Statistics

Valuation Measures

Market Capitalization2

2.06M

Enterprise Value

-3.82M

Enterprise Value/EBITDA(ttm)

0.49

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.33

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-182.34%

Return on Invested Capital(ttm)

-217.48%

Return on Assets(ttm)

-141.27%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-7.80M

Net Income Available to Common(ttm)

-7.98M

Diluted EPS(ttm)

-18.75

Share Statistics

Beta (5Y Monthly)

1.40

52-Week Change

-90.77%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

1.43M

Dividend Yield

0.00%

Float4

1.40M

% Held by Insiders

1.86%

% Held by Institutions

16.41%

Balance Sheet

Total Cash(mrq)

5.88M

Total Cash Per Share(mrq)

4.12

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.42%

Quick Ratio(mrq)

4.42%

Book Value Per Share(mrq)

4.75

Cash Flow

Operating Cash Flow Per Share(ytd)

-9.71

Free Cash Flow(ytd)

-6.34M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement